TrialClinical breast cancer2022

A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer.

Lynn Symonds et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.